Why I’d sell this FTSE 100 growth stock for its rival’s big dividend

This growth stock’s lofty valuation has me looking at its FTSE 100 (INDEXFTSE: UKX) peer’s 3.9% yield and more reasonable valuation.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

The share price of private hospital group Mediclinic International (LSE: MDC) is down around 5% today as the market digests yet another mixed financial update from the firm. On the positive side, the company’s Southern African assets continue to perform well with local currency revenue up 4.1% and margins creeping upward. However, this performance was cancelled out by a decrease in revenue and margins in both its Swiss and UAE hospitals.

Overall, in constant currency terms, group revenue was flat and underlying EBITDA was down 5% year-on-year (y/y). While both revenue and profits were up in real terms due to the weak pound, investors should mainly concern themselves with how the business is actually performing since management can’t control currency movements.

5 Stocks For Trying To Build Wealth After 50

One notable billionaire made 99% of his current wealth after his 50th birthday. And here at The Motley Fool, we believe it is NEVER too late to start trying to build your fortune in the stock market. Our expert Motley Fool analyst team have shortlisted 5 companies that they believe could be a great fit for investors aged 50+ trying to build long-term, diversified portfolios.

Click here to claim your free copy now!

Aside from South Africa, there was some good news on this front in the six months to September as management disclosed it was confident that struggling Middle Eastern operations would post positive sales and profit growth in H2. This is good to hear as some of the group’s hospitals in the Emirates have struggled with high staff turnover and weak demand following their acquisition. The company says doctor vacancies have now stabilised, but unfortunately the local market remains highly competitive, which is likely to keep margins well below group average for some time.

Overall, the company is not one I’d like to invest in today. Net debt following the reverse takeover of Al Noor Hospitals in 2015 is still relatively high at £1.6bn or 3.3 times full-year EBITDA, and problems in the UAE business have proven stubbornly difficult to put right. Add in a lofty valuation of 21 times trailing earnings and I see better places to invest my cash.

Utilising all the tools it has 

One company that’s caught my eye is water utility Severn Trent (LSE: SVT). It offers a solid 3.9% dividend yield and trades at 14 times earnings, despite its share price rising a respectable 27% over the past five years.

While regulated utilities are far from growth stars, Severn Trent’s management team has proven very capable of squeezing extra profits out of the business by cutting costs and exceeding regulatory efficiency targets that come with multi-million pound incentives.

For the year to March 2018, it is targeting outperforming outcome delivery incentives to the tune of £23m. On top of these bonus payments, management has found some £770m in cost efficiencies over the five-year review period from 2015-20. Together these have supported steady dividend increases while keeping customers’ average water bills the lowest in the UK.

Looking forward, the firm is prepared to see its regulated rates fall for the 2020-25 review period as regulators want to lower utility bills for consumers. This will, of course, be bad news for Severn Trent, which is why its share price has dropped 16% since May. But unlike competitors, it has proven very capable of cutting fat and hitting targets to maintain and grow profits.

With a bumper dividend, great recent operational history and increasingly attractive valuation, Severn Trent is one stock well worth a closer look.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Ian Pierce has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Smiling senior white man talking through telephone while using laptop at desk.
Investing Articles

How I’d invest a Stocks and Shares ISA with a 10-year time frame

Our writer explains how he focusses his Stocks and Shares investment choices by using a long-term perspective.

Read more »

UK money in a Jar on a background
Investing Articles

3 reasons to consider the 7% Legal & General dividend yield

The Legal & General dividend yield of 7% is one reason our writer would consider buying the shares for his…

Read more »

macro shot of computer monitor with FTSE 100 stock market data in trading application
Investing Articles

Should I buy this FTSE 250 defensive stock?

Jabran Khan is looking for defensive stock options for his holdings and delves deeper into this FTSE 250 food manufacturing…

Read more »

pink toy piggy money box on yellow background
Investing Articles

5 ‘no-brainer’ FTSE 250 shares to buy today

I'm seeing a lot of attractive dividend shares in the FTSE 250 right now. This approach gives me some very…

Read more »

Windmills for electric power production.
Investing Articles

The SSE share price slumps by 11%! Should I buy today?

The SSE share price tumbled today after talks of a windfall tax on electricity generators. Our writer considers if it’s…

Read more »

British Pennies on a Pound Note
Investing Articles

3 penny shares I own instead of Woodbois

Our writer prefers these three penny shares over hot stock Woodbois -- which is why he has bought them.

Read more »

Senior Man Sitting On Sofa At Home With Pet Labrador Dog
Investing Articles

This FTSE 100 stock has tumbled in price. Here’s why I’d buy it now!

This FTSE 100 stock has tumbled to nearly half of its value since the start of 2022. This presents a…

Read more »

Playful senior couple in aprons dancing and smiling while preparing healthy dinner at home
Investing Articles

My top 5 big dividend stocks to buy before June!

With soaring inflation, I'm looking at dividend stocks to increase my returns in the near term and keep my portfolio…

Read more »